HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Namiki Izumi Selected Research
Namiki Izumi Research Topics
Disease
105
Hepatocellular Carcinoma (Hepatoma)
11/2022 - 11/2003
67
Chronic Hepatitis C
10/2022 - 04/2003
50
Infections
10/2022 - 10/2003
39
Fibrosis (Cirrhosis)
10/2022 - 12/2003
23
Hepatitis C
01/2022 - 09/2003
22
Neoplasms (Cancer)
11/2022 - 11/2005
22
Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 09/2007
18
Chronic Hepatitis B
11/2021 - 12/2003
14
Liver Diseases (Liver Disease)
01/2022 - 01/2005
10
Disease Progression
05/2022 - 01/2003
8
Thrombocytopenia (Thrombopenia)
10/2020 - 09/2011
7
Ascites
06/2022 - 02/2015
7
Hepatitis B
10/2021 - 01/2011
6
Chronic Hepatitis (Chronic Active Hepatitis)
10/2021 - 01/2003
6
Hepatitis
09/2021 - 01/2003
5
Liver Neoplasms (Liver Cancer)
02/2019 - 01/2013
4
Hemorrhage
04/2021 - 01/2016
4
Anemia
10/2020 - 09/2011
4
Thrombosis (Thrombus)
10/2020 - 02/2018
4
Headache (Headaches)
11/2016 - 06/2014
3
Non-alcoholic Fatty Liver Disease
02/2022 - 12/2019
3
Carcinogenesis
10/2021 - 01/2017
3
Fatty Liver
10/2021 - 08/2010
3
Neutropenia
10/2020 - 03/2015
3
Diarrhea
12/2016 - 06/2014
3
Nasopharyngitis
11/2016 - 06/2014
3
Neoplasm Metastasis (Metastasis)
10/2015 - 08/2012
2
Cholangiocarcinoma
08/2021 - 08/2021
2
COVID-19
01/2021 - 01/2020
2
Varicose Veins (Varicose Vein)
08/2020 - 03/2020
2
Hepatitis E
10/2018 - 01/2010
Drug/Important Bio-Agent (IBA)
51
Interferons
IBA
11/2021 - 09/2003
47
Ribavirin (Virazole)
FDA Link
Generic
10/2019 - 04/2003
31
Antiviral Agents (Antivirals)
IBA
07/2022 - 01/2008
25
Sorafenib (BAY 43-9006)
FDA Link
11/2022 - 09/2010
12
Biomarkers (Surrogate Marker)
IBA
10/2022 - 06/2006
11
Albumins
IBA
07/2022 - 09/2011
11
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2022 - 01/2006
11
DNA (Deoxyribonucleic Acid)
IBA
10/2021 - 12/2003
10
lenvatinib
IBA
11/2022 - 06/2019
9
wisteria lectin
IBA
10/2021 - 09/2015
9
Alanine Transaminase (SGPT)
IBA
01/2018 - 01/2006
8
Fetal Proteins (Fetoprotein)
IBA
11/2022 - 01/2011
8
Sofosbuvir
IBA
10/2022 - 11/2014
8
Hepatitis B e Antigens
IBA
10/2021 - 12/2003
7
Bilirubin
IBA
06/2022 - 07/2009
7
Carrier Proteins (Binding Protein)
IBA
10/2021 - 12/2018
7
Proteins (Proteins, Gene)
FDA Link
10/2019 - 11/2005
7
Pharmaceutical Preparations
IBA
01/2019 - 12/2004
7
RNA (Ribonucleic Acid)
IBA
08/2015 - 01/2010
6
Nucleotides
IBA
10/2021 - 06/2015
6
Nucleosides
IBA
10/2021 - 01/2005
6
Antigens
IBA
10/2021 - 09/2002
6
tenofovir alafenamide
IBA
09/2021 - 11/2016
6
lusutrombopag
IBA
04/2021 - 01/2019
6
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2018 - 01/2010
6
Simeprevir
IBA
12/2015 - 05/2014
6
Interferon-alpha (Interferon Alfa)
IBA
03/2013 - 01/2003
5
daclatasvir
IBA
05/2022 - 01/2014
5
Tolvaptan
FDA Link
01/2022 - 01/2016
5
Transaminases (Aminotransferases)
IBA
01/2018 - 01/2006
5
Creatinine
IBA
11/2016 - 09/2011
4
asunaprevir
IBA
05/2022 - 06/2014
4
acarboxyprothrombin (PIVKA)
IBA
01/2022 - 04/2012
4
Hepatitis B Surface Antigens (HBsAg)
FDA Link
06/2020 - 02/2014
4
Tenofovir (Viread)
FDA Link
11/2019 - 11/2016
4
Tumor Biomarkers (Tumor Markers)
IBA
10/2019 - 11/2005
4
Amino Acids
FDA Link
01/2017 - 12/2010
4
Lamivudine (Epivir)
FDA Link
02/2010 - 12/2003
3
velpatasvir
IBA
10/2022 - 07/2018
3
Tyrosine Kinase Inhibitors
IBA
05/2022 - 08/2019
3
Diuretics
IBA
01/2022 - 06/2016
3
Carnitine (L-Carnitine)
FDA Link
Generic
11/2020 - 08/2015
3
Serum Albumin
IBA
01/2020 - 10/2013
3
entecavir
FDA Link
01/2020 - 01/2010
3
Sonazoid
IBA
07/2019 - 01/2014
3
Collagen
IBA
01/2019 - 06/2013
3
Therapeutic Uses
IBA
02/2018 - 01/2010
3
Messenger RNA (mRNA)
IBA
01/2017 - 09/2003
2
Prothrombin (Factor II)
IBA
01/2022 - 01/2011
2
Vasopressins (Vasopressin)
IBA
01/2022 - 06/2016
2
Indicators and Reagents (Reagents)
IBA
01/2021 - 02/2018
2
Immunoglobulin M (IgM)
IBA
01/2021 - 01/2020
2
Immunoglobulin G (IgG)
IBA
01/2021 - 01/2020
2
Prodrugs
IBA
11/2019 - 01/2018
2
regorafenib
IBA
10/2019 - 08/2019
2
elbasvir
IBA
10/2019 - 01/2019
2
Protease Inhibitors (Protease Inhibitor)
IBA
10/2019 - 01/2019
2
grazoprevir
IBA
10/2019 - 01/2019
2
glecaprevir and pibrentasvir
IBA
10/2019 - 07/2019
2
ledipasvir
IBA
10/2018 - 06/2015
Therapy/Procedure
103
Therapeutics
11/2022 - 01/2003
11
Radiofrequency Ablation
01/2022 - 09/2007
5
Aftercare (After-Treatment)
01/2022 - 08/2014
5
Drug Therapy (Chemotherapy)
01/2022 - 01/2018
5
Platelet Transfusion (Blood Platelet Transfusions)
04/2021 - 01/2018
5
Liver Transplantation
07/2016 - 09/2007
4
Hepatectomy
01/2022 - 01/2020
4
Renal Dialysis (Hemodialysis)
07/2019 - 12/2015
3
Drug Tapering
09/2011 - 01/2011